Analyzing MRD levels is vital to both indicating achievement of a deep molecular response (remission) in response to oncological therapy as well as potential reoccurrence of cancer (relapse).
Mapping DNA methylation patterns to study gene silencing and epigenetic markers associated with various diseases.
Monitors how immune cells respond to infections or trigger autoimmune conditions (like rheumatoid arthritis or lupus) by mapping gene expression changes.
Profiles gene expression in tumor tissues to classify cancer subtypes, predict patient prognosis, and guide targeted therapies.
Maps expression at the individual cell level, discovering hidden cellular diversity and specific responses that are otherwise masked in bulk tissue analysis.
